The Coronavirus Brief | Update: FDA committee approves boosters for some

And other recent COVID-19 news |

Email not displaying correctly? View it in your browser.

Friday, September 17, 2021, Supplemental BY ALICE PARK Update: FDA Advisory Committee OKs Boosters for Vulnerable Groups In its final vote, a U.S. Food and Drug Administration (FDA) advisory committee decided unanimously to recommend COVID-19 booster doses to people over age 65, and those at high risk of getting the disease, including health care, frontline and essential workers. The recommendation only applies to a booster dose of Pfizer-BioNTech's vaccine, which is already approved for controlling the disease. The decision came after the committee members initially voted 16 to 2 against the original request from Pfizer-BioNTech, which was to recommend booster doses for all people vaccinated with the companies' shot so far. The panel asked the FDA to reword the voting question to focus on the most vulnerable populations, and then unanimously supported the more restrictive use of boosters.

Want more from TIME? Sign up for our other newsletters. Subscribe to TIME

TIME may receive compensation for some links to products and services in this email. Offers may be subject to change without notice.   Connect with TIME via Facebook | Twitter | Newsletters   UPDATE EMAIL     UNSUBSCRIBE    PRIVACY POLICY   YOUR CALIFORNIA PRIVACY RIGHTS   TIME Customer Service, P.O. Box 37508, Boone, IA 50037-0508   Questions? Contact coronavirus.brief@time.com   Copyright © 2021 TIME USA, LLC. All rights reserved.